{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:53:01Z","timestamp":1793141581815,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Basic and Applied Research Foundation of Guangdong","award":["2020A1515110733"],"award-info":[{"award-number":["2020A1515110733"]}]},{"name":"the Stomatological Hospital of Southern Medical University Research Fund","award":["RC202006"],"award-info":[{"award-number":["RC202006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03442-1","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:16:36Z","timestamp":1764173796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polyethylene glycol loxenatide reduces NETosis and immunofluorescence hyperactivation in Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"30","author":[{"given":"Fang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"6","key":"3442_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","volume":"12","author":"Y Yazici","year":"2010","unstructured":"Yazici Y, Yurdakul S, Yazici H. Behcet\u2019s syndrome. Curr Rheumatol Rep. 2010;12(6):429\u201335.","journal-title":"Curr Rheumatol Rep"},{"issue":"8697","key":"3442_CR2","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet's disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet\u2019s Disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"7","key":"3442_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1346-8138.2003.tb00423.x","volume":"30","author":"S Uzun","year":"2003","unstructured":"Uzun S, Alpsoy E, Durdu M, Akman A. The clinical course of Behcet\u2019s disease in pregnancy: a retrospective analysis and review of the literature. J Dermatol. 2003;30(7):499\u2013502.","journal-title":"J Dermatol"},{"issue":"4","key":"3442_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A Gul","year":"2015","unstructured":"Gul A. Pathogenesis of Behcet\u2019s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37(4):413\u20138.","journal-title":"Semin Immunopathol"},{"issue":"12","key":"3442_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H. Autoimmunity vs autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006;45(12):1461\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3442_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623\u20135.","journal-title":"Nat Med"},{"issue":"5663","key":"3442_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135.","journal-title":"Science"},{"issue":"3","key":"3442_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677\u201391.","journal-title":"J Cell Biol"},{"issue":"2","key":"3442_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231\u201341.","journal-title":"J Cell Biol"},{"issue":"3","key":"3442_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11739-013-1036-5","volume":"9","author":"G Emmi","year":"2014","unstructured":"Emmi G, Silvestri E, Squatrito D, D\u2019Elios MM, Ciucciarelli L, Prisco D, et al. Behcet\u2019s syndrome pathophysiology and potential therapeutic targets. Intern Emerg Med. 2014;9(3):257\u201365.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"3442_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann Rheum Dis. 2018;77(6):808\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3442_CR12","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M, et al. Mortality in Behcet\u2019s disease. Arthritis Rheum. 2010;62(9):2806\u201312.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3442_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","volume":"61","author":"H Hendarto","year":"2012","unstructured":"Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R, et al. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism. 2012;61(10):1422\u201334.","journal-title":"Metabolism"},{"key":"3442_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429333261241021034043","volume":"17","author":"Y Bseiso","year":"2024","unstructured":"Bseiso Y, Gammoh O, Alqudah M, Altaber S, Qnais E, Wedyan M, et al. Evaluating the anti-inflammatory efficacy of a novel bipyrazole derivative in alleviating symptoms of experimental colitis. Curr Mol Pharmacol. 2024;17:e18761429333261.","journal-title":"Curr Mol Pharmacol"},{"issue":"8","key":"3442_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588\u2013606.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3442_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1566523223666230731115236","volume":"24","author":"Z Miao","year":"2024","unstructured":"Miao Z, Gu M, Raza F, Zafar H, Huang J, Yang Y, et al. Isoliquiritin ameliorates ulcerative colitis in rats through Caspase 3\/HMGB1\/TLR4 dependent signaling pathway. Curr Gene Ther. 2024;24(1):73\u201392.","journal-title":"Curr Gene Ther"},{"issue":"4","key":"3442_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/0115665232273077240104045022","volume":"24","author":"S Sriramulu","year":"2024","unstructured":"Sriramulu S, Malayaperumal S, Banerjee A, Anbalagan M, Kumar MM, Radha RKN, et al. AEG-1 as a novel therapeutic target in colon cancer: a study from silencing AEG-1 in BALB\/c mice to large data analysis. Curr Gene Ther. 2024;24(4):307\u201320.","journal-title":"Curr Gene Ther"},{"issue":"2","key":"3442_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107\u201319.","journal-title":"Nat Rev Rheumatol"},{"key":"3442_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behcet\u2019s disease: a comprehensive review. J Autoimmun. 2015;64:137\u201348.","journal-title":"J Autoimmun"},{"issue":"5","key":"3442_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","volume":"14","author":"G Emmi","year":"2019","unstructured":"Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, et al. Vascular Behcet\u2019s syndrome: an update. Intern Emerg Med. 2019;14(5):645\u201352.","journal-title":"Intern Emerg Med"},{"issue":"5 Suppl 24","key":"3442_CR21","first-page":"S19","volume":"19","author":"E Eksioglu-Demiralp","year":"2001","unstructured":"Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behcet\u2019s disease. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S19-24.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"3442_CR22","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.2337\/db14-0976","volume":"64","author":"J Koska","year":"2015","unstructured":"Koska J, Sands M, Burciu C, D\u2019Souza KM, Raravikar K, Liu J, et al. Exenatide protects against glucose- and lipid-induced endothelial dysfunction: evidence for direct vasodilation effect of GLP-1 receptor agonists in humans. Diabetes. 2015;64(7):2624\u201335.","journal-title":"Diabetes"},{"key":"3442_CR23","volume":"2012","author":"U Tursen","year":"2012","unstructured":"Tursen U. Pathophysiology of the Behcet\u2019s disease. Pathol Res Int. 2012;2012:493015.","journal-title":"Pathol Res Int"},{"issue":"4","key":"3442_CR24","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/jdv.16117","volume":"34","author":"O Ducharme","year":"2020","unstructured":"Ducharme O, Schollhammer R, Leduc J, Baubion E, Farid K, Amazan E. Lymphatic drainage abnormalities in a child presenting as an unilateral vulvar swelling: a case of \u201cBicyclist\u2019s vulva.\u201d J Eur Acad Dermatol Venereol. 2020;34(4):e171\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"3442_CR25","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1007\/s10067-021-05755-y","volume":"40","author":"CC Hou","year":"2021","unstructured":"Hou CC, Ma HF, Ye JF, Luo D, Bao HF, Guan JL. Plasma exosomes derived from patients with intestinal Behcet\u2019s syndrome induce intestinal epithelial cell pyroptosis. Clin Rheumatol. 2021;40(10):4143\u201355.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3442_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3442_CR27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","volume":"11","author":"M Karmakar","year":"2020","unstructured":"Karmakar M, Minns M, Greenberg EN, Diaz-Aponte J, Pestonjamasp K, Johnson JL, et al. N-GSDMD trafficking to neutrophil organelles facilitates IL-1beta release independently of plasma membrane pores and pyroptosis. Nat Commun. 2020;11(1):2212.","journal-title":"Nat Commun"},{"key":"3442_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101189118","author":"KW Chen","year":"2021","unstructured":"Chen KW, Demarco B, Ramos S, Heilig R, Goris M, Grayczyk JP, et al. RIPK1 activates distinct gasdermins in macrophages and neutrophils upon pathogen blockade of innate immune signaling. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2101189118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3442_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3094642","volume":"2016","author":"YS Lee","year":"2016","unstructured":"Lee YS, Jun HS. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediators Inflamm. 2016;2016:3094642.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"3442_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000480373","volume":"10","author":"RS Doster","year":"2018","unstructured":"Doster RS, Rogers LM, Gaddy JA, Aronoff DM. Macrophage extracellular traps: a scoping review. J Innate Immun. 2018;10(1):3\u201313.","journal-title":"J Innate Immun"},{"key":"3442_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","volume":"4","author":"A Abderrazak","year":"2015","unstructured":"Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296\u2013307.","journal-title":"Redox Biol"},{"key":"3442_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142965","author":"A Gupta","year":"2022","unstructured":"Gupta A, Singh K, Fatima S, Ambreen S, Zimmermann S, Younis R, et al. Neutrophil extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14142965.","journal-title":"Nutrients"},{"key":"3442_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109252","volume":"332","author":"L Zhang","year":"2020","unstructured":"Zhang L, Tian J, Diao S, Zhang G, Xiao M, Chang D. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1beta-induced metabolic disturbance and mitochondrial dysfunction. Chem Biol Interact. 2020;332:109252.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"3442_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3442_CR35","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s00125-010-1831-8","volume":"53","author":"Y Hattori","year":"2010","unstructured":"Hattori Y, Jojima T, Tomizawa A, Satoh H, Hattori S, Kasai K, et al. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Diabetologia. 2010;53(10):2256\u201363.","journal-title":"Diabetologia"},{"issue":"1","key":"3442_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/BOR.0000000000000666","volume":"32","author":"Y Yazici","year":"2020","unstructured":"Yazici Y. Management of Behcet syndrome. Curr Opin Rheumatol. 2020;32(1):35\u201340.","journal-title":"Curr Opin Rheumatol"},{"issue":"19","key":"3442_CR37","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"3442_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","volume":"57","author":"AE Hogan","year":"2014","unstructured":"Hogan AE, Gaoatswe G, Lynch L, Corrigan MA, Woods C, O\u2019Connell J, et al. Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus. Diabetologia. 2014;57(4):781\u20134.","journal-title":"Diabetologia"},{"issue":"12","key":"3442_CR39","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","volume":"74","author":"JS Knight","year":"2015","unstructured":"Knight JS, Subramanian V, O\u2019Dell AA, Yalavarthi S, Zhao W, Smith CK, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann Rheum Dis. 2015;74(12):2199\u2013206. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205365.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3442_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248\u201361.","journal-title":"Nat Rev Immunol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03442-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03442-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03442-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:16:37Z","timestamp":1764173797000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03442-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3442"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03442-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013), and approved by the Laboratory Animal Ethics Committee of Southern Medical University's. All participants confirmed the information in this study and signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1187"}}